Balaxi Pharmaceuticals Limited

NSE:BALAXI.NS

88.32 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Revenue 637.736580.471607.85547.209659.554806.812865.817659.554806.812890.992617.236702.297583.353529.531659.9603.291520.584117.083131.43125.52382.28859.64462.08814.22200000-6.163000.0190.0540.2270.020.1740.3910.766
Cost of Revenue 389.996301.61303.609291.206403.134510.792527.338403.134510.792609.912419.965510.666415.421378.279495.4455.341392.44285.91387.231100.861.82346.53647.31210.85100.0190000.0080000.0120000.0140
Gross Profit 247.74278.861304.241256.003256.42296.02338.479256.42296.02281.08197.271191.631167.932151.252164.5147.95128.14231.1744.19824.72320.46513.10914.7763.3710-0.019000-6.171000.0190.0420.2270.020.1740.3780.766
Gross Profit Ratio 0.3880.480.5010.4680.3890.3670.3910.3890.3670.3150.320.2730.2880.2860.2490.2450.2460.2660.3360.1970.2490.220.2380.237000001.0010010.7871110.9641
Reseach & Development Expenses 000000000000000000000000000000000000000
General & Administrative Expenses 92.962112.52590.68382.73599.14499.775110.62599.14499.77536.72635.79528.6230.26863.0600021.3570004.9180000.3750000.1990000.1720000.150
Selling & Marketing Expenses 81.0296.5520008.40700010.214022.69701.0180001.0180000.1540000.2530000.0430000.030000.0410
SG&A 173.991112.52590.68382.73599.14499.775110.62599.14499.77546.9435.79551.31730.26899.32921.820.92119.20332.8194.8834.1164.1755.0723.5361.3830.3750.6280.3750.3750.3750.2420.1650.1650.1650.2020.1340.1540.1130.1910.03
Other Expenses -173.991-174.818-1.3232.799-10.081-2.20276.805-10.08180.689117.39427.46252.48811.729-35.7466.715.7515.0976.0996.9856.1563.2694.8992.5490.641.3022.1640.0043.4560.6610.4510.2580.0190.4510.0150.5140.00101.414-0.47
Operating Expenses 197.391174.818172.454154.969170.871180.464187.43170.871180.464164.33463.25752.48854.72433.1850.345.63938.5918.37716.5815.0489.456.3895.4341.8151.3022.1641.4223.4560.6610.4510.2580.2270.4510.2750.5140.2210.2291.414-0.47
Operating Income 73.749104.043130.464103.83375.468113.353105.39675.468113.353151.218130.012140.473124.93699.877120.9118.061104.64940.42834.60315.83214.28414.79711.8911.556-1.302-2.164-1.419-3.456-0.661-6.614-0.258-0.208-0.433-0.206-0.372-0.2-0.0540.1521.23
Operating Income Ratio 0.1160.1790.2150.190.1140.140.1220.1140.140.170.2110.20.2140.1890.1830.1960.2010.3450.2630.1260.1740.2480.1920.109000001.07300-23.073-3.814-1.639-10.204-0.3120.391.606
Total Other Income Expenses Net -22.18710.89312.26652.775-469.589-2.67-0.139-469.589-2.67-1.015-0.231-0.145-0.025-0.184000-16.410-0-0-3.18900.640-0.02000-0.086-0.106-0.104-0.097-0.084-0.085-0.044-0.25-0.0910.562
Income Before Tax 73.749114.936142.73156.608-394.121110.683105.257-394.121110.683150.203129.781140.328124.91199.693120.9118.061104.64924.01734.60315.83214.28411.60811.8912.196-1.302-2.164-1.419-3.456-0.661-6.7-0.364-0.312-0.53-0.29-0.372-0.244-0.3040.0611.23
Income Before Tax Ratio 0.1160.1980.2350.286-0.5980.1370.122-0.5980.1370.1690.210.20.2140.1880.1830.1960.2010.2050.2630.1260.1740.1950.1920.154000001.08700-28.262-5.376-1.639-12.452-1.7460.1571.606
Income Tax Expense 8.9455.5986.79412.32219.30929.68122.96919.30929.68123.0987.98519.78717.77516.11911.316.90817.6199.4389.8654.4213.9744.7340-0.640-0.020000.0860.1060.1040.097-0.3590.0850.0440.250.0250.423
Net Income 64.804109.338135.936144.286-413.4381.00282.288-413.4381.002127.105121.795120.541107.13783.574109.6101.15387.0314.5824.73911.4110.316.87411.8912.196-1.302-2.164-1.419-3.456-0.661-6.7-0.364-0.312-0.530.069-0.372-0.244-0.3040.0370.807
Net Income Ratio 0.1020.1880.2240.264-0.6270.10.095-0.6270.10.1430.1970.1720.1840.1580.1660.1680.1670.1250.1880.0910.1250.1150.1920.154000001.08700-28.2621.282-1.639-12.452-1.7460.0931.054
EPS 1.172.082.662.82-8.11.61.64-8.272.832.542.442.412.141.672.192.021.7426.380.490.230.680.450.780.14-0.086-0.14-0.094-0.23-0.044-0.036-0.024-0.021-0.0340.007-0.024-0.016-0.020.0020.054
EPS Diluted 1.172.082.642.81-8.11.571.61-8.272.832.542.442.412.141.672.192.021.7426.380.490.230.680.450.780.14-0.086-0.14-0.094-0.23-0.044-0.036-0.024-0.021-0.0340.007-0.024-0.016-0.020.0020.054
EBITDA 78.67110.754135.274110.44378.321125.228107.25778.321125.228152.946131.581141.644125.59100.155122.2118.834105.30640.46134.62115.84514.29614.8111.8982.196-1.287-2.149-1.417-3.454-0.659-6.608-0.256-0.205-0.43-0.198-0.282-0.194-0.0510.161.238
EBITDA Ratio 0.1230.1910.2230.2020.1190.1550.1240.1190.1550.1720.2130.2020.2150.1890.1850.1970.2020.3460.2630.1260.1740.2480.1920.154000001.07200-22.922-3.665-1.242-9.921-0.2930.4091.616